Skip to main content

Table 10 Findings from the Sapporo and Hokkaido cohorts on the relationships between exposures and allergies and infectious diseases

From: The Hokkaido Birth Cohort Study on Environment and Children’s Health: cohort profile—updated 2017

Exposures

Outcome

Number

Findings

Reference

Sapporo cohort

 Dioxins

Otitis media

364

Polychlorinated dibenzofuran was associated with increased risk among male infants (OR 2.5, 95% CI 1.1–5.9).

2,3,4,7,8-pentachlorodibenzo-furan was associated with increased risk of otitis media (OR 5.3, 95% CI 1.5–19).

[53]

 PFASs

Cord IgE/infectious disease

343

Cord IgE levels decreased with high maternal PFOA concentration among females.

No associations among maternal PFOS and PFOA levels and food allergy, eczema, wheezing, or otitis media in the 18-month-old infants.

[54]

Hokkaido cohort

 PFASs

Eczema

2063

At 24 months, the risk in association with higher maternal PFTrDA levels decreased (OR 0.62, 95% CI 0.45–0.86).

[32]

 

Total allergic diseases/eczema/wheezing

1558

ORs in the Q4 vs. Q1 for total allergic diseases decreased for PFDoDA (OR 0.621, 95% CI 0.454–0.847) and PFTrDA (OR 0.712, 95% CI 0.524–0.966). OR (Q4 vs. Q1) for wheezing in relation to higher maternal PFHxS levels was 0.728 (95% CI 0.497–1.06).

[56]

 

Infectious diseases

1558

PFHxS was associated with higher risk of total infections disease among girls (Q1 vs. Q4: OR 1.55, 95% CI 0.976–2.45).

[55]

  1. IgE immunoglobulin E, Q quartile, OR odds ratio, PFASs perfluorinated alkyl substances, PFDoDA perfluorododecanoic acid, PFHxS perfluorohexane sulfonate, PFOA perfluorooctanoic acid, PFOS perfluorooctanoic sulfonate, PFTrDA perfluorotridecanoic acid, CI confidence interval